Alpha-1 Antitrypsin Deficiency is believed to be diagnosed in only 4% of people who have it. Since it is most often associated with COPD and Bronchiectasis, respiratory therapists can play an important role in its identification and treatment. This online course from the AARC is aimed at significantly improving knowledge of this under-recognized disease.

Approved for 3.0 CRCE Hours

**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**

User reviews for Emerging Roles for the RT in Alpha 1 Anti-trypsin Deficiency:

"Great course!""Very well done!""Really enjoyed learning more about this subject.""Very helpful."

Seminar Information

Seminar Date:

January 01, 2017

Expiration Date:

December 31, 2017 11:59 PM

Seminar Objectives

Explain the pathobiology of Alpha-1 Antitrypsin Deficiency (A1ATD)

Identify the prevalence of A1ATD

Identify the clinical manifestations of A1ATD

Describe the pathogenesis of emphysema and bronchiectasis in A1ATD

Discuss the genetic link of A1ATD

Identify the types of testing for A1ATD

Define COPD and the impact of COPD

Identify the purpose of COPD disease staging

Discuss disease management goals for COPD

Discuss the history, rationale, and controversies for augmentation therapy in A1ATD